Cannabimimetic eicosanoids in cancer and inflammation: An update

Advances in Experimental Medicine and Biology

Volumn 507, Issue , 2002, Pages 381-386

  Melck, Dominique ^a   Bisogno, Tiziana ^a   De Petrocellis, Luciano ^b   Beaulieu, Pierre ^c   Rice, Andrew S C ^c   Di Marzo, Vincenzo ^a  

^a CNR   (Italy)

^b CNR   (Italy)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; BML 190; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; ICOSANOID; PALMIDROL; PROLACTIN; TURPENTINE; UNCLASSIFIED DRUG; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; AMIDE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL ASSAY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYSTITIS; DERIVATIZATION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EXTRACTION; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; RAT; ANIMAL; ARTICLE; BLADDER; BREAST TUMOR; CELL CULTURE; CELL DIVISION; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALIA;

ANIMALS; ARACHIDONIC ACIDS; BREAST NEOPLASMS; CANNABINOIDS; CELL DIVISION; EICOSANOIDS; FEMALE; GLYCERIDES; HUMANS; INFLAMMATION; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; TUMOR CELLS, CULTURED; URINARY BLADDER;

EID: 0038446501     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0193-0_59     Document Type: Conference Paper

References (16)

1. V. Di. Marzo, T. Bisogno, L. De Petrocellis, D. Melck, and B.R. Martin. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. Curr Med Chem 6:721 (1999).
2. D.M. Lambert and V.Di marzo. The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic? Curr Med Chem 6:757 (1999).
3. T. Bisogno, S. Maurelli, D. Melck, L. De Petrocellis, and V. Di Marzo. Biosynthesis, uptake, and degradation of anadamide and palmitoylethanolamide in leukocytes. J. Biol. Chem. 272:3315 (1997).
4. V.K. Pestonjamasp, and S.H. Burstein. Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. Biochem. Biophys. Acta 1394:249 (1998).
5. V. Di Marzo, T. Bisogno, T. Sugiura, D. Melck, and L. De Petrocellis. The novel endogenous cannabinoid 2-arachydonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anadamide. Biochem J. 331: 15 (1998).
6. V. Di Marzo, T. Bisogno, L. De Petrocellis, D. Melck, P. Orlando, J.A. Wagner, and G. Kunos. Biosynthesis and inactivation of the endocannabinoid 2-arachydonoylglycerol in circulating and tumoral macrophages. Eur.J.Biochem. 264:258 (1999).
7. V. Di Marzo, D. Melck, L. De Petrocellis, and T. Bisogno. Cannabimimetic fatty acid derivatives in cancer and inflammation. Prostaglandins and other lipid mediators in press (2000).
8. L. De Petrocellis, D. Melck, A. Palmisano, T. Bisogno, C. Laezza, M. Bifulco, and V. Di Marzo. The endogenous cannabinoid anadamide inhibits human breast cancer cells proliferation. Proc.Natl.Acad.Sci.U.S.A. 95:8375 (1998).
9. D. Melck, L. De Petrocellis, P. Orlando, T. Bisogno, C. Laezza, M. Bifulco, and V. Di Marzo. Supression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 141:118 (2000).
10. D. Melck, D. Rueda, I. Galve-Roperh, L. De Petrocellis, M. Guzman, and V. Di Marzo. Inhibition of the cAMP/protein kinase A pathway and stimulation of mitogen-activated protein kinase underlie the anti-proliferative effects of anadamide in human breast cancer cells, FEBS Lett. 463:235 (1999).
11. T. Bisogno, K. Katayama, D. Melck, N. Ueda, L. De Petrocellis, S. Yamamoto, and V. Di Marzo. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells: implications for the cell proliferation and differentiation. Eur.J.Biochem. 254:634 (1998).
12. N. Dmitrieva, D. Shelton, A.S.C Rice, and S.B. Mcmahon. The role of nerve growth factor in a model of visceral inflammation. Neuroscience 78:449 (1997).
13. P. Beaulieu, T. Bisogno, S. Punwar, W.P. Farquhar-Smith, G. Ambrosino, V. Di Marzo, and A.S.C. Rice. Role of endogenous cannabinoid system in the formalin test of persistent pain in the rat. Eur.J.Pharmacol. in press (2000).
14. S. Mazzari, R. Canella, L. Petrelli, G. Marcolongo, and A. Leon. N-(2-hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur.J.Pharmacol. 300:227 (1996).
15. A. Calignano, G. La Rana, A. Giuffrida, and D. Piomelli. Control of pain initiation by endogenous cannabinoids. Nature 394:277 (1998).
16. S. Ben-Shabat, E. Fride, T. Sheskin, T. Tamiri, M.H. Rhee, Z. Vogel, T. Bisogno, L. De Petrocellis, V. Di Marzo, and R. Mechoulam. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur.J.Pharmacol. 353:23 (1998).